Reddit Posts
Why $MBOT is about to explode.. A whole new class of medical robots at an absolute steal!
$MBOT - Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
Microbot Medicals VP spoilers big news
If anyone is looking for a GREEN day on a heavy RED day of trading... MBOT
Huge news for Microbot Medical ($MBOT) ahead of full commercial rollout
MBOT adopted by top tier Florida Hospital
What Softer Inflation Does to High Beta Stocks
Why I think $MBOT is the most undervalued, overlooked, multi-bagger around.
Microbot Medical (MBOT) — Deep-Dive: Financials, LIBERTY Adoption, Cash Burn, Dilution Risk & Implied Share Price (Including the New Hospital Adoption News)
$MBOT. Finally, refering after my last post
MBOT | Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
Microbot Medical® (MBOT) Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
MBOT: High risk, but the upside at this price is HUGE
$MBOT is Officially entering commercionalization phase
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
MBOT during overnight trading hours.
$MBOT Superpower: A Board That Delivers Deals and Results!
Added MBOT to robotics watchlist, testing a data-driven approach
Benzinga All Access Interview with MBOT's CEO Harel Gadot | Q4 2025 limited US market release of LIBERTY® Endovascular Robotic System | April 2026 full US market release of LIBERTY® Endovascular Robotic System | Harel also hinted at Microbot Medical entering Cardiovascular and Neurovascular space!
MBOT CEO - Benzinga Livestream Interview Today 10:45 AM ET
DD on $MBOT - Microbot Medical- just approved by FDA!
# DD on $MBOT - Microbot Medical: The Next Big MedTech Explosion?
# DD on $MBOT - Microbot Medical: The Next Big MedTech Explosion?
Microbot Medical Inc.(NasdaqCM: MBOT) added to S&P Global BMI Index
MBOT - Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
🚨 Microbot Medical (NASDAQ: MBOT) – Major FDA Milestone + Investor Conference 🚨
New to the stock game. Holding ONDS & CGTX
$MBOT – FDA approval + insane volume = warrant overhang almost gone
NRx Pharmaceuticals (NRXP) -- Is anyone seeing a pattern here? Third analyst enters, and now with a $40 price target ... AND ... NRx's HOPE Therapeutics closes on Dura Medical clinic acquisition in Florida! This journey is quickly unfolding per plan. Comprehensive post link below. A WINNER HERE!
$MBOT device is approved and it’ll pop once the news comes out
$MBOT: FDA clearance confirmed, perfect timing with major catalysts ahead
🚨 MBOT Gets FDA 510(k) Clearance 🚨
MBOT receives FDA Substantially Equivalent 510(k) Premarket Notification, 09/04/2025, for LIBERTY Endovascular Robotic System (LIBERTYOS)
Looking to expand my pro folio
Guidance for new trader on penny stocks
🚨 Microbot Medical (MBOT) – LIBERTY Robotic System Nears FDA 510(k) Clearance 🚨
The Warrant Overhang Everyone Feared Is Becoming MBOT’s Biggest Bull Case
Am I out of my mind holding ENLV?
MBOT upcoming FDA catalyst concerns
Microbot Medical. Is there a big opportunity here? Would like to hear your opinions.
Reddit Ticker Mentions - AUG.22.2025 - $PLTR, $WWR, $NVDA, $TNFA, $IXHL, $MBOT, $CGTX, $APM, $PGEN, $OPEN
Reddit Ticker Mentions - AUG.22.2025 - $PLTR, $WWR, $NVDA, $TNFA, $IXHL, $MBOT, $CGTX, $APM, $PGEN, $OPEN
MBOT and TIGR steady rise testing Dec 2024 highs.
MBOT broke out of this year's ascending triangle today
MBOT Microbot Medical New Patent Granted
Reddit Ticker Mentions - AUG.21.2025 - $PLTR, $NVDA, $AMD, $WWR, $TNFA, $CGTX, $THAR, $MBOT, $QQQ, $INTC
Reddit Ticker Mentions - AUG.21.2025 - $PLTR, $NVDA, $AMD, $WWR, $TNFA, $CGTX, $THAR, $MBOT, $QQQ, $INTC
$MBOT Microbot Medicinal have been granted US patent
Top 5 For Traders: Breakouts, Rebounds, And A Round-Number Flip
MBOT (Microbot Medical) – FDA Catalyst Around the Corner
QUBT OR MBOT? I'm going to drop 20k on one of them today. Thoughts?
MBOT Huge Opportunity Ahead with FDA Catalyst & Short Squeeze Setup
Reddit Ticker Mentions - AUG.11.2025 - $AMD, $NVDA, $QQQ, $AAPL, $RKLB, $LULU, $MBOT, $PLTR, $CTM, $ONDS
Reddit Ticker Mentions - AUG.11.2025 - $AMD, $NVDA, $QQQ, $AAPL, $RKLB, $LULU, $MBOT, $PLTR, $CTM, $ONDS
Microbot Medical (MBOT) - Numerous openings for Area Sales Mgrs and a Marketing Comms (Marcom) Mgr. FDA approval expected in Q3 2025 and product launch in Q4 2025.
Tickers Referenced In Reddit Posts - Not AI Slop
Microbot Medical (MBOT) - We know an FDA approval decision is expected in Q3 2025. Why would certain entities be betting against approval of such a highly successful robotic system in human trials? Take note of this potential opportunity!
What is your view MBOT
MBoT - An incoming Rocket 🚀
Microbot Medical (MBOT): Q3 Catalyst on the Horizon 🚀
🧠 Microbot Medical ($MBOT) – Near-Term FDA Milestone & Commercial Planning Update
🚨 Microbot Medical ($MBOT) — FDA Decision Approaching & Commercial Gameplan Locked In 🚀
Stryker's vascular business likely exceeds $2B in annual revenue and they serve the majority of hospitals in the U.S. MBOT's novel peripheral endovascular robotic system (Liberty) would make a great fit.
$MBOT unusual call options activity today... Heavily shorted small AI bio name another MEME play ready for squeeze!
$MBOT unusual call options activity today... Heavily shorted small AI bio name another MEME squeeze
Mentions
Damn MBOT to 4$ you held that stock for months 😅😅 at least you are still breathing
IOVA got pretty sexy today! 😍 Still carrying my hopium bags for similar run on MBOT....hopefully in my lifetime 🤣
MBOT..shorts all over it
MBOT..great news just now! https://www.stocktitan.net/sec-filings/MBOT/8-k-microbot-medical-inc-reports-material-event-14001ed547c0.html
Anti-WEN people invented MBOT
Let me pull the actual Microbot Medical (MBOT) data to check the numbers. Quick verdict: the headline "99% Short Interest" is flat-out wrong. The real number is about **12.5%**. Here's the check against live data (MBOT, as of the 6/26 close): **What's accurate:** - Price $1.77, down 4.32%. Matches. - Short interest of 7,640,438 shares. That's the NASDAQ-reported figure and it looks legit. - Days-to-cover 9.21. Roughly checks out: 7.64M short shares divided by the ~823K two-week average volume is ~9.3 days. Consistent. **What's wrong:** - "99% short interest" appears nowhere in the data shown and isn't close to reality. Short interest as a percent is short shares divided by float (or shares outstanding). MBOT has ~61M float and ~67M shares outstanding. So: - 7.64M / 61M float = **12.5% of float** - 7.64M / 67M shares out = **11.4% of shares outstanding** To actually have 99% short interest, you'd need ~60M shares sold short, not 7.6M. Off by roughly 8x. **Where the "99%" likely comes from:** classic conflation of *short volume* with *short interest*. The screenshot itself shows "Off-Exchange Short Volume 55.86%," which is the share of one day's dark-pool volume that printed short. That's a daily flow metric that routinely runs 40 to 60%+ on almost any stock, because it includes market-maker hedging that nets back out by the close. It has nothing to do with how much of the float is actually held short. Someone either misread one of those volume fields, pulled "99%" from a daily short-volume spike on a low-volume day, or just made it up for the squeeze hype. r/smallstreetbets does this constantly. **Honest takeaway:** 12.5% of float short with ~9 days to cover is *elevated but ordinary* for a small-cap biotech. It's "moderately shorted," not a coiled 99% squeeze. The genuinely notable thing here isn't the short interest, it's that this is a $119M-market-cap, pre-revenue, money-losing (negative P/E) microcap down ~62% from its 52-week high. The short thesis is probably just "it's a cash-burning clinical-stage name," and the squeeze framing is doing a lot of work that the actual data doesn't support.
MBOT has to be a sophisticated pump by some kind of group. All the comments and posts about 99% SI which can be easily debunked by a simple google search of the float.
Let me pull the actual Microbot Medical (MBOT) data to check the numbers. Quick verdict: the headline "99% Short Interest" is flat-out wrong. The real number is about **12.5%**. Here's the check against live data (MBOT, as of the 6/26 close): **What's accurate:** - Price $1.77, down 4.32%. Matches. - Short interest of 7,640,438 shares. That's the NASDAQ-reported figure and it looks legit. - Days-to-cover 9.21. Roughly checks out: 7.64M short shares divided by the ~823K two-week average volume is ~9.3 days. Consistent. **What's wrong:** - "99% short interest" appears nowhere in the data shown and isn't close to reality. Short interest as a percent is short shares divided by float (or shares outstanding). MBOT has ~61M float and ~67M shares outstanding. So: - 7.64M / 61M float = **12.5% of float** - 7.64M / 67M shares out = **11.4% of shares outstanding** To actually have 99% short interest, you'd need ~60M shares sold short, not 7.6M. Off by roughly 8x. **Where the "99%" likely comes from:** classic conflation of *short volume* with *short interest*. The screenshot itself shows "Off-Exchange Short Volume 55.86%," which is the share of one day's dark-pool volume that printed short. That's a daily flow metric that routinely runs 40 to 60%+ on almost any stock, because it includes market-maker hedging that nets back out by the close. It has nothing to do with how much of the float is actually held short. Someone either misread one of those volume fields, pulled "99%" from a daily short-volume spike on a low-volume day, or just made it up for the squeeze hype. r/smallstreetbets does this constantly. **Honest takeaway:** 12.5% of float short with ~9 days to cover is *elevated but ordinary* for a small-cap biotech. It's "moderately shorted," not a coiled 99% squeeze. The genuinely notable thing here isn't the short interest, it's that this is a $119M-market-cap, pre-revenue, money-losing (negative P/E) microcap down ~62% from its 52-week high. The short thesis is probably just "it's a cash-burning clinical-stage name," and the squeeze framing is doing a lot of work that the actual data doesn't support.
The MBOT short interest is 7 million shares against a float of 67 million. The 99% short interest is just a data anomaly, short interest is 11%
The Company intends to seek to raise additional funds through future issuances of either debt and/or equity securities and possibly additional grants from the Israeli Innovation Authority and other government institutions in order to fund further growth and expansion of the Company. The Company’s ability to raise additional capital in the equity and debt markets is dependent on a number of factors, including, but not limited to, the market demand for the Company’s stock, which itself is subject to a number of development and business risks and uncertainties, as well as the uncertainty that the Company would be able to raise such additional capital at a price or on terms that are favorable to the Company. https://ca.finance.yahoo.com/sec-filing/MBOT/0001493152-26-022792_883975/
Quick verdict: the headline "99% Short Interest" is flat-out wrong. The real number is about **12.5%**. Here's the check against live data (MBOT, as of the 6/26 close): **What's accurate:** - Price $1.77, down 4.32%. Matches. - Short interest of 7,640,438 shares. That's the NASDAQ-reported figure and it looks legit. - Days-to-cover 9.21. Roughly checks out: 7.64M short shares divided by the ~823K two-week average volume is ~9.3 days. Consistent. **What's wrong:** - "99% short interest" appears nowhere in the data shown and isn't close to reality. Short interest as a percent is short shares divided by float (or shares outstanding). MBOT has ~61M float and ~67M shares outstanding. So: - 7.64M / 61M float = **12.5% of float** - 7.64M / 67M shares out = **11.4% of shares outstanding** To actually have 99% short interest, you'd need ~60M shares sold short, not 7.6M. Off by roughly 8x. **Where the "99%" likely comes from:** classic conflation of *short volume* with *short interest*. The screenshot itself shows "Off-Exchange Short Volume 55.86%," which is the share of one day's dark-pool volume that printed short. That's a daily flow metric that routinely runs 40 to 60%+ on almost any stock, because it includes market-maker hedging that nets back out by the close. It has nothing to do with how much of the float is actually held short. Someone either misread one of those volume fields, pulled "99%" from a daily short-volume spike on a low-volume day, or just made it up for the squeeze hype. r/smallstreetbets does this constantly. **Honest takeaway:** 12.5% of float short with ~9 days to cover is *elevated but ordinary* for a small-cap biotech. It's "moderately shorted," not a coiled 99% squeeze. The genuinely notable thing here isn't the short interest, it's that this is a $119M-market-cap, pre-revenue, money-losing (negative P/E) microcap down ~62% from its 52-week high. The short thesis is probably just "it's a cash-burning clinical-stage name," and the squeeze framing is doing a lot of work that the actual data doesn't support.
Totally different category.. RBOT is for abdominal surgery.. MBOT is strictly endovascular (catheters) Plus, RBOT is stuck in massive delays.. MBOT is already in Full Market Release!! and pulling in real commercial revenue! Different league.
I consider buying cheap calls for robotics pennystocks MBOT, RR and ARBE.
Just filled order for MBOT earnings next week. Last revenue was disaster I believe this Q will be nice surprise 🤞
Student investor here, not as knowledgeable as most people here but i am hoping my massive investment (from student standards) in MBOT (microbot medical) takes off. I researched on my own quite a bit and now just hope it takes off after their Full market release.
Anybody follow $MBOT ? They announced full market release to the US today and it tanked 10%…?
Don't miss your opportunity to buy $MBOT now before it moons next week
Holy shit. Good call. I'm still mad at myself. I had 15k worth of calls from like November 24 until like March 25. Was up and down between $80 - $110 the whole time. I got frustrated and sold and didn't buy back even when they were in the low 60's. I told myself "buy 40k worth of shares, sell half when it doubles, then let the rest ride for a couple of years." Talked myself out of that too and bought MBOT instead. MU makes me sad every time I see the symbol now.
Microbot medical, MBOT. Full commercialization release this month!
MBOT and QSI will eventually play out
I have a fear with RCKT bc my friend invested in this stock last year when patient died in trials and the stock fell pretty hard after that. My friend stills hold the stock though waiting for the pump up in price. I feel that I have overextended my portfolio with biotech related stuff (DRTS, IMRX, MBOT, MDAI). Yesterday I added 100 shares to DRTS, DDD, NB, CTM, PDYN, MBOT and Kopin (Ondas and UMAC bought Kopin shares with 2.10 price last September for long-term potential, my average is 2.22 and sitting with 300+ shares, earnings coming up in a week or two) I also bought 200 shares of Canadian Uranium mining company Denison Mines which is under 4$ right now, should be a good entry price but there seems to be a dilution fear with it right now)
I actually changed my mind yesterday and sold all my LifeMD stock for the time being for 40% profit and decided to move that money to MBOT (bought 213 shares, it has 2 catalysts coming up in 1 month time and don't want to pay premium for the stock later, it has already FDA approval and it probably has a dilution also coming up during a year but it seemed like a good idea for me to get it at 2.79 price before it rallies further) and the rest to IMRX (currently have 246 shares of it at 5.56). I added LifeMD stock to my watchlist for the time being and buy in again. Now we both have to root for the price drop and shorters to short it in the meantime lol
LWLG had a blow off last night. Curious to see how much of a run it can sustain. MBOT has been steadily climbing and building momentum. CDXS reported a profitable quarter and EPS .15 higher than estimates with decent guidance for the year. CDXS is a biotech company that synthesizes proteins using proprietary technology. Stock is trading $1 off last October levels and $1.5 off its 52 week high. They are building a new facility so I don’t think the profitability continues all year but near term I see them making most of that back. LWLG is a data center play that just signed a partnership with TSEM. They have a proprietary polymer they claim transmits data faster and uses less energy. MBOT is my favorite. They make robot spiders that crawl up your butt and save your life and stuff.
Microbot medical MBOT! Currently 2.55 but should be easily over 5.00 end of May. FDA approved remote peripheral endovascular robotic surgery Liberty system currently in a limited market launch. Emory hospital has already announced adoption of the liberty system. Full commercialization is in April. This could be massive!!!! Over 2.5 million procedures annually in the USA!
I’m very bullish on $MBOT (Microbot Medical). The recent hospital news shows that their technology is gaining real-world traction. If this platform proves itself in clinical settings, it could be truly revolutionary for the future of minimally invasive surgery.
I would just like to say, I really love you guys!! Hahaha. I appreciate the help that this community offers. Obviously you gotta weed out the bots and bullshit, but for a beginning trader, I’ve made 10% on my portfolio in two weeks. Some big winners some big losers but I’ll take 10% with a smile on my face. Thanks for the help chaps! And with that let’s see SLS, MBOT, and MSS bring in some skirlla! 💰
As a major investor in MBOT I welcome this announcement, but I think the folks that expect the stock to "quadruple" need a shot of reality. 1) This is simply a joint press-release - one might call it a self-promotion, 2) the main message from Tampa General is that they believe in the future of robotics. This could, and probably does, simply translate to the hospital agreed to accept a few free machines and test them. Again, this is good news, one of the necessary steps for MBOT to grow, but nothing more material than that. As I outlined on a previous post there are several competitors to MBOT that have various approaches, Microbot going after the very low-end endovascular procedures by having a very simple, low-cost machine and not having haptic feedback and also no integrated systems like monitoring or gas control. Although this is a fraction of the TAM, the SAM is huge and they appear to be the leader in this segment. They need a successful launch in April followed by real sales. Given all that - if they do quadruple anytime soon all of my following posts will be from the beach.
Unless we some major shift in the full scale release I should be at least. Love me some MBOT 🥰🥰🥰
That’s a fair question. As of now, MBOT has been positioning itself for full commercial rollout following FDA clearance, and recent hospital adoptions (like Tampa General) suggest forward progress rather than distress. However, as with most pre revenue or early commercial med tech companies, dilution is always a possibility if additional capital is needed to scale manufacturing, expand sales infrastructure, or accelerate adoption. A reverse split typically only becomes a concern if a company risks falling out of compliance with exchange listing requirements and there’s no indication of that at the moment. Ultimately, whether current share structure and cash are sufficient depends on how quickly revenue ramps post launch. If adoption accelerates and revenues follow, dilution risk decreases. If rollout takes longer than expected, capital raises are common in this stage of growth. Scaling phase = execution risk, but recent momentum is encouraging.
Absolutely stoked on $MBOT. Been in the red on them for a while unfortunately, but I think this is easily going to double once commercialization is under way and we start to see positive earnings reports :)
Yes sir! Didn’t even realize you had already shared this news when I made another post on it. Fantastic for MBOT and a huge validation of their LIBERTY system.
Don’t sleep on MBOT my friends
Thanks for reading guys! Very excited about the interest Liberty has garnered so far during the limited commercial release. Patience is paying off for $MBOT holders.
$HGRAF and $MBOT going absolutely buck wild LFGGGGG
$MBOT got in at 2.15!! gonna hold it for couple years.
Ty for sharing that’s very informative. I will be investing in SLS in the very near future. If you have any free time could you please look into Microbot Medical MBOT and share your opinion on them. I have been following them for 2 years and invested in their stock. Thanks again
a slower one to watch...MBOT if it breaks 2.20...this may be a good runner
I would recommend looking into Microbot Medical MBOT. FDA approval last December, limited release right now, scheduled full market launch in April. They have the Liberty system a remote robotic single use system, for peripheral endovascular surgeries. Emory University has already announced they will be adopting this system at their medical facilities. This is not a get rich over night stock, in my opinion it has huge potential in the short term if they can scale production as needed. There are currently over 2.5 million procedures this system could be used for annually in the USA. Not financial advice, best of luck everyone!
I bought in on that IVDA dip, hoping to see them BLNK, and FEMY break a dollar in the coming month. ONL, GGB, NSPCY, PLBY, MBOT, DFLI I'm holding till penny stock graduation. I think its fully possible for these peeps.
MBOT pumping in premarket. They presented at the CIO recently.
MBOT's story is consistent even as the years change, but I've never bought it.
Love MBOT at this price. For a BUY and HOLD.
Yeah, Sell your bags and buy a winner. MBOT is garbage stock.
My usual DFLI, GGB, ONL, PLBY, MBOT, BLNK, FEMY, ADIL, IGC
 MBOT you say?
Been watching MBOT for a while and bought in at 4.9 and sold for a loss on the way down. Bought back in today as I have belief in the long term outlook. Company messaging and scaling up is bang on. Just a matter of time now.....
This is actually a legitimate technology that was tested by some of the best hospitals in the world. I have been following MBOT for ~10 months, largely because I narrowly avoided a complicated cardiovascular procedure from bloodclot complications. I'm healthy compared to the cardiovascular disaster that is the future of the USA. I don't think anybody knows how to value the Liberty system's future. I'm in for
Buying more $MBOT $HGRAF $EOSE all for the 1-3 year timeframe I’ll eat my socks if I don’t at least 2-3x by then
IGC, ADIL, DFLI, FEMY, MBOT, PLBY, GGB, BLNK <3 As for crypto FLOKI, and XRP are heavy on my radar
ACHR. RR. MBOT. HIVE all undervalued and overlooked.
IGC, ADIL for possible commiceralization of their products this year. DFLI, and BLNK with the rise of EV; and a Impending EV mandate. MBOT, FEMY since they start commercialization; bd started pursuing profits. ONL as it should be mostly underway with its assest reassessment which should generate more income abroad. GGB for a long term hold towards rebuilding efforts with Venezuela, and possibly Ukraine if the north american or South america segments decide to export to them (but still probably unlikely atleast from the north american segment with tarrifs). PLBY for retail hype, aswell as possible expanding into profitability going into 2026.
Genuine question for all the cheerleaders of MBOT...can someone give a good reason why this company will succeed when it has had MULTIPLE reverse splits between 2011-2018 **Multiple reverse splits have occurred for this company** **1-for-10 reverse split** on **July 6, 2011** **1-for-12 reverse split** on **May 9, 2016** **1-for-9 reverse split** on **November 28, 2016** **1-for-15 reverse split** on **September 4, 2018**
Genuine question for all the cheerleaders of MBOT...can someone give a good reason why this company will succeed when it has had MULTIPLE reverse splits between 2011-2018 **Multiple reverse splits have occurred for this company** **1-for-10 reverse split** on **July 6, 2011** **1-for-12 reverse split** on **May 9, 2016** **1-for-9 reverse split** on **November 28, 2016** **1-for-15 reverse split** on **September 4, 2018**
MBOT about to blow up this year
I will look into everything you post if I can figure out how to follow you. If you have time please look into Microbot Medical MBOT. I believe this could go up over 400percent by end of May 2026. Just curious on your thoughts, not interested in pumping anything.
NVNI, IXHL, MBOT, GPUS, DFLI, SCWO: The lost goes on and on, each of these stocks are down massive since being spammed on this sub
Man, ive been passive investing mostly and got along with minimum risks with ASTS, BBAI and MBOT in the past few years. Even i have more return than his max return %. Zero stress so far 🤷♂️
When I saw it being stuck at 2.69 a week prior to approval, I knew it was already priced in. The hype definitely has something to do with it as well. Reminds me of MBOT
Lowkey looking to renter playboy Holding DFLI, FEMY, MBOT, IGC, ADIL, ONL, and IVDA for 2026s bull run
MBOT gained 23% on the day it was approved. Gave it all back in two days that is true. Biggest difference though is that MBOTs approval was for a robotic surgery medical device. Much lower margins and market size vs a pharmaceutical.
I would remind everybody that MBOT got approval, too. Buy the rumor, sell the news.
I personally like DFLI, FEMY, IGC, ADIL, ONL, MBOT, and IVDA. The most promising is probably the first 5 tho. I would do dd, but if you have any questions on then from ne; I'll be happy to do my best to answer them.
MBOT is straight up a scam. Here are its many names in the past: 1988: Cellular Transplants 1992: Cytotherapeutics, Inc 2000: StemCells, Inc 2016: Renamed “Microbot Medical, Ltd.
DFLI, FEMY, IGC, ADIL, ONL, IVDA, MBOT, CHR (My Pennystock holds, feel free to ask me why) <3
I have some robotics stock options RR, SERV and MBOT where options are cheap with small spread
I kinda like MBOT. Once I secure more capital, I might invest in them long term
will go into MBOT, RR and MYO tomorrow
Your right no penny stock comes without a risk, however if your concerned with my picks I cant give you a list. MBOT (accumulating for possible profitability next year goal being 4$+) PLBY, My retail pick that broke profitability (found at .89 selling 3$×+) BTLCY, for a reliable and stable REIT with plenty of cash on hand; and prime tenants (found at 4.55 selling 5.10+) DFLI (found at .25, selling 2$+ innovated EV batteries for larger vehicles; and was recognized by both the trucking and battwry community for its innovations with their products) FEMY (found at .75, selling 1.10$+ Innvated Feminine OBGYN care currently going without much contesting in their market since IVF fell) ONL (found 2.10, selling 2.40 REIT thats pays divedends that has a ceo thats a natural to flipping REIT companies; and was confident out valuing a buy out offer they recently turned down) IVDA a data center in arizona thats the easiest of the states data centers to be put on the market (found at .65 selling 1.10$+) Less then 10$, but not penny stocks Nokia (Divdend paying services company. riding out till end of its billion dollar nivida contract in 2026. Found 5.50) Adt (dividend paying serives company. riding out till end of google contract in 2026. Found at 8.15) Overall a services company being out of debt with high institutional/ceo ownership, doesn't mean they have a for sure way to secure profits.
I bought in to $MBOT. At the very least this $2 stock should quadruple in the next year or two as more hospitals adopt their system.
Done with pump and dumps (for now lol), just holding FEMY and MBOT and chill instead of chasing thrill.
[MBOOOOT](http://aimytrade.io/ticker/MBOT)
Interesting milestone for MBOT. Regulatory approval will be the real catalyst to watch before the stock can gain momentum.
DFLI going up and MBOT also flying!!
if you're looking for penny stocks with value and which are constantly returning value, look into QIMC, MBOT, LITM. remember, penny stocks are not going to be 'safe' but when you catch the right one at the right position, well, that's your entire target for the year. these aren't the slow/steady type.
MBOT has some strong pre market volume.
Go pump MBOT for my measly call option experiment I opened on Wednesday please lol.